Sostek M - Search Results

1

Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteers.

Miner P Jr, Plachetka J, Orlemans E, Fort JG, Sostek M. Miner P Jr, et al. Among authors: sostek m. Aliment Pharmacol Ther. 2010 Aug;32(3):414-24. doi: 10.1111/j.1365-2036.2010.04361.x. Epub 2010 May 18. Aliment Pharmacol Ther. 2010. PMID: 20491746 Clinical Trial.

2

Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers.

Miner PB Jr, Tutuian R, Castell DO, Liu S, Sostek MB. Miner PB Jr, et al. Clin Ther. 2006 May;28(5):725-33. doi: 10.1016/j.clinthera.2006.05.001. Clin Ther. 2006. PMID: 16861094 Clinical Trial.

3

Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone.

Goldstein JL, Hochberg MC, Fort JG, Zhang Y, Hwang C, Sostek M. Goldstein JL, et al. Among authors: sostek m. Aliment Pharmacol Ther. 2010 Aug;32(3):401-13. doi: 10.1111/j.1365-2036.2010.04378.x. Epub 2010 May 22. Aliment Pharmacol Ther. 2010. PMID: 20497139 Clinical Trial.

4

Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults.

Pisegna JR, Sostek MB, Monyak JT, Miner PB Jr. Pisegna JR, et al. Among authors: sostek mb. Aliment Pharmacol Ther. 2008 Mar 15;27(6):483-90. doi: 10.1111/j.1365-2036.2007.03592.x. Epub 2007 Dec 19. Aliment Pharmacol Ther. 2008. PMID: 18162083 Free PMC article. Clinical Trial.

5

A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.

Cryer BL, Sostek MB, Fort JG, Svensson O, Hwang C, Hochberg MC. Cryer BL, et al. Ann Med. 2011 Dec;43(8):594-605. doi: 10.3109/07853890.2011.625971. Epub 2011 Oct 22. Ann Med. 2011. PMID: 22017620 Free article. Clinical Trial.

6

Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers.

Sostek MB, Fort JG, Estborn L, Vikman K. Sostek MB, et al. Curr Med Res Opin. 2011 Apr;27(4):847-54. doi: 10.1185/03007995.2011.555756. Epub 2011 Feb 14. Curr Med Res Opin. 2011. PMID: 21319944 Clinical Trial.

7

Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux disease.

Metz DC, Miner PB, Heuman DM, Chen Y, Sostek M. Metz DC, et al. Among authors: sostek m. Aliment Pharmacol Ther. 2005 Nov 1;22(9):813-21. doi: 10.1111/j.1365-2036.2005.02659.x. Aliment Pharmacol Ther. 2005. PMID: 16225490 Clinical Trial.

8

Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.

Miner P Jr, Katz PO, Chen Y, Sostek M. Miner P Jr, et al. Among authors: sostek m. Am J Gastroenterol. 2003 Dec;98(12):2616-20. doi: 10.1111/j.1572-0241.2003.08783.x. Am J Gastroenterol. 2003. PMID: 14687806 Clinical Trial.

9

Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials.

Hochberg MC, Fort JG, Svensson O, Hwang C, Sostek M. Hochberg MC, et al. Among authors: sostek m. Curr Med Res Opin. 2011 Jun;27(6):1243-53. doi: 10.1185/03007995.2011.580340. Epub 2011 Apr 28. Curr Med Res Opin. 2011. PMID: 21524238 Clinical Trial.

10

Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.

Wang-Smith L, Fort J, Zhang Y, Sostek M. Wang-Smith L, et al. Among authors: sostek m. J Clin Pharmacol. 2012 May;52(5):670-80. doi: 10.1177/0091270011405500. Epub 2011 May 31. J Clin Pharmacol. 2012. PMID: 21628602 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters